Frequently Asked Questions
The market is segmented based on Global Nerve Growth Factor (NGF) Market, By Type (Alpha-NGF, Beta-NGF, Gamma-NGF, Others), Indication (Neurodegenerative Disorders, Spinal Cord Injuries, Eye Disorders, Epithelial Diseases, Tissue Healing, Others), Regulation (Endocrine System (Neuro), Immune System, Others), Agents (Cenegermin, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030
.
The Global Nerve Growth Factor Ngf Market size was valued at USD 1.07 USD Billion in 2022.
The Global Nerve Growth Factor Ngf Market is projected to grow at a CAGR of 7.9% during the forecast period of 2023 to 2030.
The major players operating in the market include Dompé farmaceutici, Pfizer, Regeneron Pharmaceuticals, Astellas Pharma, Merck, Sanofi, Promega Corporation, Alomone Labs, BioRad Laboratories, Prospec, Tany Technogene, CUSABIO TECHNOLOGY, Biocare Medical, Lilly, Teva Pharmaceutical Industries, Mitsubishi Chemical Group Corporation.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
